Estimating the risks and benefits before salvage surgery for recurrent head and neck squamous cell carcinoma

被引:7
|
作者
Locatello, Luca Giovanni [1 ,2 ]
Mastronicola, Romina [1 ,5 ]
Cortese, Sophie [1 ]
Beulque, Emilie [1 ]
Salleron, Julia [3 ]
Gallo, Oreste [2 ,4 ]
Dolivet, Gilles [1 ,5 ]
机构
[1] Univ Lorraine, Inst Cancerol Lorraine, Dept Surg Oncol, Head & Neck Unit, F-54519 Vanduvre Les Nancy, France
[2] Careggi Univ Hosp, Dept Otorhinolaryngol, Largo Brambilla 3, I-50134 Florence, Italy
[3] Univ Lorraine, Inst Cancerol Lorraine, Biostat Unit, F-54519 Vanduvre Les Nancy, France
[4] Univ Florence, Dept Expt & Clin Med, Florence, Italy
[5] Univ Lorraine, CRAN, CNRS, F-54000 Nancy, France
来源
EJSO | 2021年 / 47卷 / 07期
关键词
Head and neck surgery; Radiotherapy; Salvage surgery; Recurrence; Head and neck cancer; CLAVIEN-DINDO CLASSIFICATION; BODY-MASS INDEX; COMORBIDITY INDEX; SURGICAL SALVAGE; METASTATIC HEAD; COMPLICATIONS; CANCER; SURVIVAL; MORTALITY; RADIOTHERAPY;
D O I
10.1016/j.ejso.2021.01.022
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: The risks associated with salvage surgery of head and neck squamous cell carcinoma (SCC) in a previously irradiated field needs to be balanced against the expected survival benefits. We want to identify preoperative predictive factors for overall and disease-specific survival (OS/DSS) and for the development of serious (Clavien-Dindo, CD>III) complications following salvage surgery for radio-recurrent SCC to help surgeons, patients, and caregivers in the decision-making process in this setting. Materials and methods: The records of 234 patients presenting to the Lorraine Cancer Institute with locoregional radiorecurrent SCC were reviewed. The primary endpoint was OS, secondary endpoints were DSS, OS without tracheostomy/gastrostomy, and the risk of CD>III complications. Multivariate analyses were carried out to explore preoperative factors associated with survival and the risk of post -operative complications. Results: With a median follow-up time of 19 months, 5-year OS since the first salvage surgery was 28.3%, 5-year DSS was 38.9%. 2-and 5-year functional OS were 45.6% and 27.2%. rcT-rcN, and WUNHCI >4 were both independent significant preoperative predictors of OS and DSS. 30-days postoperative complica-tions occurred in 44.4% of patients (28 CD I, 24 CD II, 34 CD III, 11 CD IV, 7 CD V). A salvage procedure involving T+N plus the presence of a WUHNCI >4 was the only independent predictor of CD>III complications. Conclusion: When discussing with the patients and the caregivers salvage surgery for recurrent head and neck SCC, a careful evaluation of the preoperative comorbidities by the WUHNCI tool can reliably predict the expected risks and benefits from the procedure. (c) 2021 Elsevier Ltd, BASO -The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:1718 / 1726
页数:9
相关论文
共 50 条
  • [31] When is reoperative surgery not indicated for recurrent head and neck squamous cell carcinoma?
    Rodrigo, Juan P.
    Kowalski, Luiz P.
    Silver, Carl E.
    de Bree, Remco
    Rinaldo, Alessandra
    Shaha, Ashok R.
    Strojan, Primoz
    Elsheikh, Mohamed N.
    Haigentz, Missak, Jr.
    Sanabria, Alvaro
    Coskun, H. Hakan
    Takes, Robert P.
    Ferlito, Alfio
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2015, 272 (02) : 259 - 262
  • [32] Salvage chemotherapy after progression on immunotherapy in recurrent/metastatic squamous cell head and neck carcinoma
    Llop, Sandra
    Plana, Maria
    Tous, Sara
    Ferrando-Diez, Angelica
    Brenes, Jesus
    Juarez, Marc
    Vidales, Zara
    Vilajosana, Esther
    Linares, Isabel
    Arribas, Lorena
    Duch, Maria
    Fulla, Marta
    Brunet, Aina
    Lozano, Alicia
    Cirauqui, Beatriz
    Mesia, Ricard
    Oliva, Marc
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [33] Prognosis after salvage chemotherapy for locally unresectable recurrent squamous cell carcinoma of the head and neck
    Kohno, N
    Kitahara, S
    Kawaida, M
    Ohmuma, T
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1999, 29 (10) : 462 - 466
  • [34] Locoregionally Recurrent Head and Neck Squamous Cell Carcinoma
    Wu, S. Y.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S174 - S174
  • [35] Elective Neck Dissection During Salvage Surgery for Locally Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy With Elective Nodal Irradiation
    Dagan, Roi
    Morris, Christopher G.
    Kirwan, Jessica M.
    Werning, John W.
    Vaysberg, Mikhail
    Amdur, Robert J.
    Mendenhall, William M.
    LARYNGOSCOPE, 2010, 120 (05): : 945 - 952
  • [36] Patterns of Failure After Salvage Surgery and Intensity Modulated Radiation Therapy Reirradiation for Recurrent Head and Neck Squamous Cell Carcinoma
    Martin, G. V.
    Takiar, V.
    Phan, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (04): : 931 - 931
  • [37] Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation
    Joris B. W. Elbers
    Lars I. Veldhuis
    Patrick A. Bhairosing
    Ludi E. Smeele
    Katarzyna Jóźwiak
    Michiel W. M. van den Brekel
    Marcel Verheij
    Abrahim Al-Mamgani
    Charlotte L. Zuur
    European Archives of Oto-Rhino-Laryngology, 2019, 276 : 647 - 655
  • [38] Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation
    Elbers, Joris B. W.
    Veldhuis, Lars I.
    Bhairosing, Patrick A.
    Smeele, Ludi E.
    Jozwiak, Katarzyna
    van den Brekel, Michiel W. M.
    Verheij, Marcel
    Al-Mamgani, Abrahim
    Zuur, Charlotte L.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2019, 276 (03) : 647 - 655
  • [39] Salvage surgery for local recurrence in head and neck squamous cell carcinoma: Oncologic results and predictive factors for successful salvage surgery
    Lee, Dong Jin
    Kwon, Kee Hwan
    Chung, Eun Jae
    Kim, Jin Hwan
    Park, Il-Seok
    Rho, Young Soo
    ORAL ONCOLOGY, 2013, 49 : S68 - S69
  • [40] Elective neck dissection during salvage surgery after radiotherapy in patients with head and neck squamous cell carcinoma
    Pedemonte, G.
    Esteller, E.
    Villator, J-C
    Costa, J-M
    Valero, C.
    Quer, M.
    Leon, X.
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2018, 38 (02) : 86 - 93